FRANCISCO LÓPEZ MEDRANO-rekin lankidetzan egindako argitalpenak (25)

2023

  1. A joint program of antimicrobial stewardship and hospital-acquired infection control to reduce healthcare-associated infections after kidney transplantation: The Hipomenes study

    American Journal of Transplantation, Vol. 23, Núm. 12, pp. 1949-1960

2022

  1. Fluconazole versus micafungin for initial antifungal prophylaxis against Candida in pancreas transplant recipients: A comparative study of two consecutive periods

    Mycoses, Vol. 65, Núm. 5, pp. 517-525

  2. Genetic polymorphisms in TLR3, IL10 and CD209 influence the risk of BK polyomavirus infection after kidney transplantation

    Scientific Reports, Vol. 12, Núm. 1

  3. Human pegivirus type 1 infection in kidney transplant recipients: Replication kinetics and clinical correlates

    Transplant Infectious Disease, Vol. 24, Núm. 1

  4. Impact of polymorphisms in genes orchestrating innate immune responses on replication kinetics of Torque teno virus after kidney transplantation

    Frontiers in Genetics, Vol. 13

  5. Influence of single-nucleotide polymorphisms in TLR3 (rs3775291) and TLR9 (rs352139) on the risk of CMV infection in kidney transplant recipients

    Frontiers in Immunology, Vol. 13

2021

  1. CMV infection, valganciclovir exposure, and the risk of BK viremia and associated nephropathy after kidney transplantation: Is there a link?

    Transplant Infectious Disease, Vol. 23, Núm. 4

2020

  1. COVID-19 in solid organ transplant recipients: A single-center case series from Spain

    American Journal of Transplantation, Vol. 20, Núm. 7, pp. 1849-1858

  2. Derivation and external validation of the SIMPLICITY score as a simple immune-based risk score to predict infection in kidney transplant recipients

    Kidney International, Vol. 98, Núm. 4, pp. 1031-1043

  3. Monitoring of CMV-specific cell-mediated immunity with a commercial ELISA-based interferon-γ release assay in kidney transplant recipients treated with antithymocyte globulin

    American Journal of Transplantation, Vol. 20, Núm. 8, pp. 2070-2080

2019

  1. Regular monitoring of cytomegalovirus-specific cell-mediated immunity in intermediate-risk kidney transplant recipients: predictive value of the immediate post-transplant assessment

    Clinical Microbiology and Infection, Vol. 25, Núm. 3, pp. 381.e1-381.e10

2018

  1. Association between baseline serum hepcidin levels and infection in kidney transplant recipients: Potential role for iron overload

    Transplant Infectious Disease, Vol. 20, Núm. 1

  2. Herpes zoster in kidney transplant recipients: protective effect of anti-cytomegalovirus prophylaxis and natural killer cell count. A single-center cohort study

    Transplant International, Vol. 31, Núm. 2, pp. 187-197

  3. Post-transplant hypocomplementemia: A novel marker of cardiovascular risk in kidney transplant recipients?

    Atherosclerosis, Vol. 269, pp. 204-210

  4. Vitamin D deficiency and infection risk in kidney transplant recipients: A single-center cohort study

    Transplant Infectious Disease, Vol. 20, Núm. 6

2017

  1. Experience with miltefosine for persistent or relapsing visceral leishmaniasis in solid organ transplant recipients: A case series from Spain

    Transplant Infectious Disease, Vol. 19, Núm. 1

  2. Serum sCD30: A promising biomarker for predicting the risk of bacterial infection after kidney transplantation

    Transplant Infectious Disease, Vol. 19, Núm. 2

  3. Therapeutisches Verhalten bei asymptomatischer Bakteriurie von Nierentransplantierten

    Nieren- und Hochdruckkrankheiten

2016

  1. Monitoring of intracellular adenosine triphosphate in CD4+ T cells to predict the occurrence of cytomegalovirus disease in kidney transplant recipients

    Transplant International, Vol. 29, Núm. 10, pp. 1094-1105

  2. Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic options

    Transplant Infectious Disease, Vol. 18, Núm. 4, pp. 575-584